-
3
-
-
0042379197
-
-
Fürstner, A.; Emst, A.; Krause, H.; Ptock, A. Tetrahedron Lett. 1996, 52, 7329.
-
(1996)
Tetrahedron Lett.
, vol.52
, pp. 7329
-
-
Fürstner, A.1
Emst, A.2
Krause, H.3
Ptock, A.4
-
4
-
-
0031800165
-
-
Zhou, L. H.; Tu, S. J.; Shi, D. Q.; Dai, G. Y.; Chen, W. X. Synthesis 1998, 851.
-
(1998)
Synthesis
, pp. 851
-
-
Zhou, L.H.1
Tu, S.J.2
Shi, D.Q.3
Dai, G.Y.4
Chen, W.X.5
-
5
-
-
0035479498
-
-
Mariappan, P.; Gadthula, S.; Surisetti, S. Tetrahedron Lett. 2001, 42, 7123.
-
(2001)
Tetrahedron Lett.
, vol.42
, pp. 7123
-
-
Mariappan, P.1
Gadthula, S.2
Surisetti, S.3
-
6
-
-
0027275916
-
-
Shi, D. Q.; Chen, J. X.; Chai, W. Y.; Chen, W. X.; Kao, T. Y. Tetrahedron Lett. 1993, 34, 2963.
-
(1993)
Tetrahedron Lett.
, vol.34
, pp. 2963
-
-
Shi, D.Q.1
Chen, J.X.2
Chai, W.Y.3
Chen, W.X.4
Kao, T.Y.5
-
7
-
-
0030697257
-
-
Shi, D. Q.; Mu, L. L.; Lu, Z. S.; Dai, G. Y. Synth. Commun, 1997, 27, 4121.
-
(1997)
Synth. Commun
, vol.27
, pp. 4121
-
-
Shi, D.Q.1
Mu, L.L.2
Lu, Z.S.3
Dai, G.Y.4
-
8
-
-
0030898481
-
-
Zhou, L. H.; Shi, D. Q.; Dai, G. Y.; Chen, W. X. Tetrahedron Lett. 1997, 38, 2729.
-
(1997)
Tetrahedron Lett.
, vol.38
, pp. 2729
-
-
Zhou, L.H.1
Shi, D.Q.2
Dai, G.Y.3
Chen, W.X.4
-
10
-
-
0000514534
-
-
(b) Blackman, A.; Hambley, T. M.; Picker, R.; Taylor, W. C.; Thirasana, N. Tetrahedron Lett. 1987, 28, 5561.
-
(1987)
Tetrahedron Lett.
, vol.28
, pp. 5561
-
-
Blackman, A.1
Hambley, T.M.2
Picker, R.3
Taylor, W.C.4
Thirasana, N.5
-
11
-
-
0028206616
-
-
(a) Helissey, P.; Cros, S.; Giorgi-Renault, S. Anti-Cancer Drug Des. 1994, 9, 51.
-
(1994)
Anti-Cancer Drug Des.
, vol.9
, pp. 51
-
-
Helissey, P.1
Cros, S.2
Giorgi-Renault, S.3
-
12
-
-
0023937674
-
-
(b) Ibrahim, E.; Montgomerie, A. M.; Sneddon, A. H.; Proctor, G. R.; Green, B. Eur. J. Med. Chem. 1988, 23, 183.
-
(1988)
Eur. J. Med. Chem.
, vol.23
, pp. 183
-
-
Ibrahim, E.1
Montgomerie, A.M.2
Sneddon, A.H.3
Proctor, G.R.4
Green, B.5
-
13
-
-
0025719308
-
-
(c)Riou, J. F.; Helissey, P.; Grondard, L.; Giorgi-Renault, S. Mol. Pharmacol. 1991, 40, 699.
-
(1991)
Mol. Pharmacol.
, vol.40
, pp. 699
-
-
Riou, J.F.1
Helissey, P.2
Grondard, L.3
Giorgi-Renault, S.4
-
14
-
-
0028671034
-
-
Brana, M. F.; Castellano, J. M.; Keilhauer, G.; Machuca, A.; Martin, Y.; Redondo, C.; Schlick, E.; Walker, N. Anti-Cancer Drug Des. 1994, 9, 527.
-
(1994)
Anti-Cancer Drug Des.
, vol.9
, pp. 527
-
-
Brana, M.F.1
Castellano, J.M.2
Keilhauer, G.3
Machuca, A.4
Martin, Y.5
Redondo, C.6
Schlick, E.7
Walker, N.8
-
15
-
-
0001276146
-
-
Li, J.; Shi, D. Q.; Chen, W. X. Heterocycles 1997, 45, 2381.
-
(1997)
Heterocycles
, vol.45
, pp. 2381
-
-
Li, J.1
Shi, D.Q.2
Chen, W.X.3
-
16
-
-
3142770673
-
-
Zhou, L. H.; Tu, S. J.; Shi, D. Q.; Dai, G. Y. J. Chem. Res., Synop. 1998, 398.
-
(1998)
J. Chem. Res., Synop.
, vol.398
-
-
Zhou, L.H.1
Tu, S.J.2
Shi, D.Q.3
Dai, G.Y.4
-
17
-
-
0141791143
-
-
Shi, D. Q.; Rong, L. C.; Wang, J. X.; Zhuang, Q. Y.; Wang, X. S.; Tu, S. J.; Hu, H. W. J. Chem. Res., Synop. 2003, 342.
-
(2003)
J. Chem. Res., Synop.
, pp. 342
-
-
Shi, D.Q.1
Rong, L.C.2
Wang, J.X.3
Zhuang, Q.Y.4
Wang, X.S.5
Tu, S.J.6
Hu, H.W.7
-
18
-
-
3142724936
-
-
note
-
4), and the solvent was removed in vacuo to give the crude product to give the pure product 3.
-
-
-
-
19
-
-
3142660448
-
-
note
-
4), and the solvent was removed in vacuo to give the crude product. The crude product was purified by column chromatography on silica gel (200-300 mesh) using petroleum ether (bp 60-90°C)-acetone (5:1) as eluent.
-
-
-
-
20
-
-
3142655995
-
-
note
-
2: C, 82.02; H, 6.02; N, 11.96. Found: C, 82.25; H, 5.89; N, 12.10.
-
-
-
-
21
-
-
18544376363
-
-
(a) Shi, D. Q.; Wang, J. X.; Shi, C. L.; Kong, L. C.; Wang, X. S.; Hu, H. W.; Yu, K. B. Acta Cryst. 2003, E59, o1846.
-
(2003)
Acta Cryst.
, vol.E59
-
-
Shi, D.Q.1
Wang, J.X.2
Shi, C.L.3
Kong, L.C.4
Wang, X.S.5
Hu, H.W.6
Yu, K.B.7
-
22
-
-
18544383117
-
-
(b) Shi, D. Q.; Wang, J. X.; Shi, C. L.; Rong, L. C.; Wang, X. S.; Hu, H. W. Acta Cryst. 2003, E59, o1661.
-
(2003)
Acta Cryst.
, vol.E59
-
-
Shi, D.Q.1
Wang, J.X.2
Shi, C.L.3
Rong, L.C.4
Wang, X.S.5
Hu, H.W.6
|